Stock BPTH BIO-PATH HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bio-Path Holdings, Inc.

Equities

BPTH

US09057N4097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.68 USD +1.71% Intraday chart for Bio-Path Holdings, Inc. -37.53% -71.06%
Apr. 19 Bio-Path Closes $1.2 Million Share Offering MT
Apr. 18 Bio-Path Holdings, Inc. Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1B Clinical Trial of Bp1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients CI

Chart calendar Bio-Path Holdings, Inc.

fd281829219d3.7A7hEW3kylybZCCgSUSWGsNZUn1LNPuKa5LuZR5tCQ0.2HuFZF6pmjLDCk3uHDzBKvsXIzoaGbjoCsWtBlwuSD6Nd65JHKmcKKMzbQ~a8059243f3a899f540dbb45e721f04d5

Upcoming events on Bio-Path Holdings, Inc.

2024-05-15 Q1 2024 Earnings Release (Projected)
2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-14 Q3 2024 Earnings Release (Projected)
2025-03-06 Q4 2024 Earnings Release (Projected)

Past events on Bio-Path Holdings, Inc.

2024-03-16 Roth Conference
2024-03-08 08:30 am Q4 2023 Earnings Call
2024-03-08 07:00 am Q4 2023 Earnings Release
2024-02-22 Reverse Split: 1 of 20
2024-01-22 05:00 pm Extraordinary Shareholders Meeting
2023-12-14 05:00 pm Annual General Meeting
2023-11-15 08:30 am Q3 2023 Earnings Call
2023-11-15 07:00 am Q3 2023 Earnings Release
2023-10-30 09:00 am Business Update Call
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference - Pre Recorded
2023-08-15 08:30 am Q2 2023 Earnings Call
2023-08-15 07:00 am Q2 2023 Earnings Release
2023-05-12 08:30 am Q1 2023 Earnings Call
2023-05-12 07:00 am Q1 2023 Earnings Release
2023-03-31 08:30 am Q4 2022 Earnings Call
2023-03-31 07:00 am Q4 2022 Earnings Release
2022-12-15 05:00 pm Annual General Meeting
2022-11-15 08:30 am Q3 2022 Earnings Call
2022-11-15 07:00 am Q3 2022 Earnings Release
2022-09-12 07:00 am H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-8,69
-8,56
-1.61%		-10,9
-11,6
5.62%		-10,4
-8,61
-21.26%		-13,9
-13,5
-2.82%		-15,8
-16,1
1.71%
-12,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-8,60
-8,49
-1.34%		-10,9
-11,5
5.64%		-10,4
-8,61
-21.26%		-13,9
-13,5
-2.69%		-16,1
-16,0
-0.41%
-12,8

Net income
Million USD		Released
Forecast
Spread 		-8,60
-8,49
-1.34%		-10,9
-11,5
5.64%		-10,4
-8,61
-21.26%		-13,9
-13,5
-2.69%		-16,1
-16,0
-0.41%
-12,8

EPS
USD		Released
Forecast
Spread 		-64,8
-63,4
-2.21%		-56,6
-60,8
6.91%		-31,0
-25,6
-21.09%		-38,2
-36,6
-4.37%		-673
-33,4
-1913.77%
-18,7

Announcement Date05/03/2009/03/2110/03/2230/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,12
-2,29
-80.1%		-3,36
-2,82
-19.11%		-3,01
-3,55
15.13%		-3,55
-3,26
-8.66%		-3,99
-3,61
-10.57%		-5,29
-3,56
-48.57%		-4,24
-4,20
-0.95%		-3,28
-3,46
5.18%		-3,03
-3,31
8.34%
-3,08


-3,16


-3,26


-3,38

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,12
-2,29
-80.09%		-3,36
-2,82
-19.16%		-3,01
-3,55
15.17%		-3,54
-3,26
-8.34%		-3,97
-3,60
-10.04%		-5,27
-3,55
-48.54%		-4,23
-4,20
-0.91%		-3,20
-3,45
7.3%		-3,37
-3,31
-1.97%
-3,06


-3,14


-3,24


-3,37

Net income
Million USD		Released
Forecast
Spread 		-4,12
-2,29
-80.09%		-3,36
-2,82
-19.16%		-3,01
-3,55
15.17%		-3,54
-3,26
-8.34%		-3,97
-3,60
-10.04%		-5,27
-3,55
-48.54%		-4,23
-4,20
-0.91%		-3,20
-3,45
7.3%		-3,37
-3,31
-1.97%
-3,06


-3,14


-3,24


-3,37

EPS
USD		Released
Forecast
Spread 		-11,8
-6,40
-84.38%		-9,40
-9,10
-3.3%		-8,40
-9,90
15.15%		-9,80
-9,10
-7.69%		-10,6
-9,00
-17.78%		-13,2
-9,00
-46.67%		-10,6
-10,4
-1.92%		-6,40
-6,80
5.88%		-84,6
-5,40
-1466.67%
-4,54


-4,60


-4,71


-4,85

Announcement Date10/03/2216/05/2215/08/2214/11/2230/03/2311/05/2314/08/2314/11/2307/03/24----

Upcoming sector events for Bio-Path Holdings, Inc.

2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-28 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-28 MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-29 04:05 pm QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Bio-Path Holdings, Inc.

Today GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-25 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 07:00 am MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
2024-04-25 02:00 am PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BPTH Stock
  4. Calendar Bio-Path Holdings, Inc.